3 completed. 3 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 3 | Completed 3 |
Follow penclomedine: new trials by email Literature Review of penclomedine trials Research Report on penclomedine
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Bioequivalence Study of BGM0504 Injection BGM0504 Injection multi-dose pen, BGM0504 Injection single-dose pen - Overweight/Obesity | Phase 1 | Completed | BrightGene Bio-Medical Technology Co., Ltd. | 144 | 2025-12-29 | 2026-10-16 |
| Penclomedine in Treating Patients With Solid Tumors or Lymphoma penclomedine - Lymphoma, Unspecified Adult Solid Tumor, Protocol Specific | Phase 1 | Completed | National Cancer Institute (NCI) | 30 | 1997-10-01 | 2013-02-11 |
| Penclomedine in Treating Patients With Advanced Solid Tumors penclomedine - Unspecified Adult Solid Tumor, Protocol Specific | Phase 1 | Completed | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 1996-12-01 | 2010-08-09 |
Burkitt Lymphoma (1) · Hodgkin Disease (1) · Immunoblastic Lymphadenopathy (1) · Leukemia, Lymphocytic, Chronic, B-Cell (1) · Lymphoma (1) · Lymphoma, B-Cell, Marginal Zone (1) · Lymphoma, Follicular (1) · Lymphoma, Large B-Cell, Diffuse (1) · Lymphoma, Large-Cell, Anaplastic (1) · Lymphoma, Large-Cell, Immunoblastic (1) · Lymphoma, Mantle-Cell (1) · Lymphoma, Non-Hodgkin (1) · Obesity (1) · Overweight (1) · Precursor Cell Lymphoblastic Leukemia-Lymphoma (1)
BrightGene Bio-Medical Technology Co., Ltd. (1) · National Cancer Institute (NCI) (1) · Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins (1)
United States (2) · China (1)
George Wilding, MD (1) · Ross C. Donehower, MD (1)
P30CA006973 (1)